Japan's Taiho Pharma has reached a deal to buy Switzerland's Araris Biotech, around 18 months after they started collaborating on the development of antibody-drug conjugates (ADCs) for cancer. Taiho ...
It’s been almost a decade since Japanese pharma company Daiichi Sankyo began its dramatic pivot from cardiovascular health into antibody-drug conjugates. For Daiichi Sankyo, it’s hard to argue that ...
Abstract: Neural network (NN) accelerators with multi-chipmodule (MCM) architectures enable integration of massive computation capability; however, they face challenges of computing resource ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results